KMT2D and neurodevelopmental disorder: Methyltransferases have been shown to be responsible for episignatures in other neurodevelopmental disorders, e.g., DNMT3A in patients with Tatton–Brown–Rahman syndrome [12] and KMT2D in Kabuki syndrome [37].